Breast Cancer clinical trials

510 recruiting studies in the US for breast cancer, cancer that forms in the cells of the breast.

Breast cancer studies are heavily weighted toward Phase 2 treatment trials, often defined by tumor type such as HR-positive, HER2-positive or triple-negative. Eligibility usually depends on stage, prior treatments and recent scans, so having your pathology report handy helps. Survivorship studies on exercise, diet and side effects are also common and often have simpler criteria.